Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
To estimate the percentage of children with serum IGF-1 > 2 standard deviation (compared to a
child of the same gender and age and without growth hormone (GH) deficiency) 9 months and 12
months after initiation of GH treatment.